Brigham & Women's Hospital, Inc. v. Teva Pharmaceuticals USA, Inc.

Federal Circuit

Brigham & Women's Hospital, Inc. v. Teva Pharmaceuticals USA, Inc.

413 F. App'x 279

CourtCourt of Appeals for the Federal Circuit

DecidedMarch 21, 2011

DocketNo. 2011-1217

StatusPublished

This text of 413 F. App'x 279 (Brigham & Women's Hospital, Inc. v. Teva Pharmaceuticals USA, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Brigham & Women's Hospital, Inc. v. Teva Pharmaceuticals USA, Inc., 413 F. App'x 279 (Fed. Cir. 2011).

Pincite

Opinion

ON MOTION

ORDER

BRYSON, Circuit Judge.

Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd., and Barr [280]*280Laboratories, Inc. (collectively Teva) move to stay proceedings in this case pending the court’s disposition in Therasense, Inc. v. Becton, Dickinson & Co., 2008-1511 et al. The appellees oppose.

Upon consideration thereof,

It Is Ordered That:

(1) The motion to stay proceedings is denied.

(2) Teva’s initial brief is due within 60 days from the date of filing of this order.

Free access — add to your briefcase to read the full text and ask questions with AI